Ritonavir-induced Cushing's syndrome in a patient treated with nasal fluticasone.
Hillebrand-Haverkort
M E
ME
Prummel
M F
MF
ten Veen
J H
JH
D000281:Administration, Intranasal; D000328:Adult; D000730:Androstadienes / Q000009:adverse effects* / Q000493:pharmacokinetics; D019380:Anti-HIV Agents / Q000494:pharmacology* / Q000627:therapeutic use; D001682:Biological Availability; D003480:Cushing Syndrome / Q000139:chemically induced*; D004347:Drug Interactions; D000068298:Fluticasone; D005938:Glucocorticoids / Q000009:adverse effects* / Q000493:pharmacokinetics; D017320:HIV Protease Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D019438:Ritonavir / Q000494:pharmacology* / Q000627:therapeutic use
D000730:Androstadienes; D019380:Anti-HIV Agents; D005938:Glucocorticoids; D017320:HIV Protease Inhibitors; D000068298:Fluticasone; D019438:Ritonavir